Bavarian Nordic — Juli 2016
-
Det var så ikke lige det vi havde brug for: http://penge.borsen.dk/artikel/1/328845/zealand_pharma_lyxumia-indtaegter_falder_10_pct.html
-
Det er ventet. Konkurrencen på GLP 1 er benhård. Sanofi har heller ikke området som særligt højt proriteret.
-
Du er altid god til at berolige Helge
-
Tak..Det går meget her på sitet og på Facebook. Det er er sværere at nå hele markedet.
-
Lidt nyt om Prostvac https://clinicaltrials.gov/ct2/show/NCT00450619?term=samarium&rank=17 og konklusionen bag fase 2 forsøget http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=10883&path[]=34461
-
Tak bb+ .
-
Hov, Bavarian er ny, så jeg vil lige høre hvad folk mener om Kerrisdales rapport omkring Prostvac? http://www.kerrisdalecap.com/wp-content/uploads/2015/08/BAVA-Report-Kerrisdale-Capital.pdf
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind